Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

CymaBay maps out regulatory filing for primary biliary cholangitis drug seladelpar – Pharmaceutical Technology

CymaBay could file for approval of its compound seladelpar in PBC early next year. Image Credit: Shutterstock / SewCreamStudio CymaBay Therapeutics could file for a

September 21, 2023

Stress in childhood linked to physical and cognitive problems in older age, according to new study

Stressful experiences during childhood could have more far-reaching effects than previously thought, contributing to issues with daily tasks like getting dressed or preparing meals in

August 3, 2023

EHR Data Holds Promise for Chronic Disease Surveillance

What You Should Know: – As chronic disease rates rise across the U.S., researchers are exploring how electronic health records (EHRs) can be used to

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.